MISSION BIOCAPITAL

mission-biocapital-logo

Mission BioCapital is a life science venture capital firm that invests in early-stage companies. The company leadership team has a long history together, investing in and launching dozens of early-stage life science companies. They are located in regions with a rich concentration of research, discovery, and venture capital investment, and they are known by leaders of portfolio companies for the expertise and deep support they provide.

#SimilarOrganizations #People #Financial #More

MISSION BIOCAPITAL

Social Links:

Industry:
Life Science Medical Venture Capital

Founded:
2009-01-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins Global Site Tag


Similar Organizations

bioadvance-logo

BioAdvance

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

Current Employees Featured

eric-w-linsley_image

Eric W. Linsley
Eric W. Linsley Managing General Partner @ Mission BioCapital
Managing General Partner
2017-01-01

douglas-crawford_image

Douglas Crawford
Douglas Crawford Managing Partner @ Mission BioCapital
Managing Partner
2020-05-01

peter-parker_image

Peter Parker
Peter Parker Managing General Partner @ Mission BioCapital
Managing General Partner
2010-01-01

eric-w-linsley_image

Eric W. Linsley
Eric W. Linsley Managing General Partner @ Mission BioCapital
Managing General Partner
2017-01-01

johannes-fruehauf_image

Johannes Fruehauf
Johannes Fruehauf General Partner, Co-Founder @ Mission BioCapital
General Partner, Co-Founder
2011-01-01

Founder


johannes-fruehauf_image

Johannes Fruehauf

peter-parker_image

Peter Parker

Investments List

Date Company Article Money raised
2022-06-14 Dren Bio Mission BioCapital investment in Series B - Dren Bio 65 M USD
2022-06-07 ImmunOs Therapeutics Mission BioCapital investment in Series B - ImmunOs Therapeutics 71 M CHF
2022-05-11 Nuvig Therapeutics Mission BioCapital investment in Series A - Nuvig Therapeutics 47 M USD
2022-02-10 Arkuda Therapeutics Mission BioCapital investment in Series B - Arkuda Therapeutics 64 M USD
2022-01-06 AmbAgon Therapeutics Mission BioCapital investment in Series A - AmbAgon Therapeutics 85 M USD
2021-12-02 Tune Therapeutics Mission BioCapital investment in Series A - Tune Therapeutics 40 M USD
2021-10-05 GraphWear Technologies Mission BioCapital investment in Series B - GraphWear Technologies 20.5 M USD
2021-09-01 Asher Bio Mission BioCapital investment in Series B - Asher Bio 108 M USD
2021-07-15 Shape Therapeutics Mission BioCapital investment in Series B - Shape Therapeutics 112 M USD
2021-06-23 Glycomine Mission BioCapital investment in Series B - Glycomine 35 M USD

More informations about "Mission BioCapital"

Life Science VC | Mission BioCapital - Mission BioCapital

Enabling Awesome Your partner in innovation Fuel your ambition Enabling Awesome. The journey from discovery to medical breakthrough demands imagination, speed, and focus. At โ€ฆSee details»

Platinum Program - Mission BioCapital

2025 Mission BioCapital Platinum Program Weโ€™re here to help you launch your life sciences company! Since 2022, the Mission BioCapital Platinum Program has funded a total of $3.5M to 8 companies located in 4 cities in the U.S. and โ€ฆSee details»

Mission BioCapital - Crunchbase Investor Profile

Mission BioCapital is a life science venture capital firm that invests in early-stage companies. The company leadership team has a long history together, investing in and launching dozens of early-stage life science companies. They are โ€ฆSee details»

Alessa Therapeutics Announces Closing $15M Seed Financing

SAN CARLOS, CA (December 12, 2024) โ€“ Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery โ€ฆSee details»

Mission BioCapital - Investments, Portfolio & Company Exits

Mission BioCapital has made 27 diversity investments. Their most recent diversity investment was on Dec 12, 2024, when Alessa Therapeutics raised. obfuscated. obfuscated. Announced Date โ€ฆSee details»

Mission BioCapital Announces 2024 Platinum Program Contest โ€ฆ

May 1, 2024 Mission BioCapital (MBC) established the Platinum Program in 2022 to enable entrepreneurs with breakthrough technologies from diverse backgrounds to quickly launch โ€ฆSee details»

Mission BioCapital Portfolio Companies - Crunchbase

Nov 10, 2015 Mission BioCapital is a life science venture capital firm that invests in early-stage companies. This list of organizations invested in by Mission BioCapital provides data on their โ€ฆSee details»

Mission BioCapital โ€“ Medium

Read writing from Mission BioCapital on Medium. Weโ€™re a VC firm making pivotal early-stage investments in biotech companies. We support companies with lab space, capital, and strategic partners; idea to exit.See details»

Mission BioCapital Raises $275 Million to Address โ€ฆ

Nov 3, 2021 Mission BioCapital gave ARase $6 million in seed funding last year and became a cofounder of the company. It plans to give between $5 million and $8 million to companies when it joins as a cofounder.See details»

Mission BioCapital Announces First Winners of Platinum Program โ€ฆ

Oct 31, 2024 Mission BioCapital, a Cambridge, MA-based announced the first eight investments supported by the Platinum Program, a competitive process managed by MBC to accelerate โ€ฆSee details»

Mission BioCapital Boosts Team - Business Wire

Dec 8, 2021 Mission BioCapital has already funded seven companies from its new fund including four where it has played a co-founder role. About Mission BioCapital Mission โ€ฆSee details»

Mission BioCapital Announces $275 Million Fund V

Nov 4, 2021 Record new fund to help biopharma startups achieve pivotal early-stage growth CAMBRIDGE, Mass. & SAN FRANCISCO, November 4, 2021โ€” Mission BioCapital, a venture โ€ฆSee details»

Mission BioCapital collects $275m for fifth fund - Venture Capital โ€ฆ

Nov 4, 2021 Mission BioCapital has raised $275 million for its fifth venture fund. Mission BioCapital V focuses on biopharma startups. PRESS RELEASE. CAMBRIDGE, Mass. & SAN โ€ฆSee details»

Mission BioCapital Announces $275 Million Fund V

Nov 4, 2021 Mission BioCapital Announces $275 million Fund V; adds Michael D. Taylor, Ph.D., and Steve Tregay, Ph.D., as partnersSee details»

Mission BioCapital - Contacts, Employees, Board Members

Mission BioCapital is a life science venture capital firm that invests in early-stage companies.See details»

Rotork management board

The Rotorkโ€™s Management Board (โ€˜RMBโ€™) is the executive committee of Rotork directors responsible for ensuring the development, implementation and execution of Group strategy.See details»

Gumax | Non-Profit Organization In Woodbridge

Gumax is a dedicated non-profit organization in Woodbridge, committed to uplifting our community through various impactful initiatives and programs. Skip to content. f; t; g; i; y; 609 โ€ฆSee details»

Simplification for success: Rewiring the biopharma operating model

2 days ago By identifying distinctive capabilities, streamlining processes, and embracing digital-first strategies, they can create more nimble organizations. Success demands a bold โ€ฆSee details»

Member Organizations & Council of Presidents - National Pan โ€ฆ

The National Pan-Hellenic Council, affectionately known as "The Divine Nine," is composed of the following member organizations: Alpha Phi Alpha Fraternity, Inc. Alpha Kappa Alpha Sorority, โ€ฆSee details»

Home - Let Them Live

Represent the life-saving work of Let Them Live on social media and help spread awareness of our mission to empower mothers and save babies. Adopt-A-Mom The Adopt-a-Mom program โ€ฆSee details»

linkstock.net © 2022. All rights reserved